CLINICAL_TRIALS trial_result · 2012-10-10

Clinical Trial Update: A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001) [Phase 2]

A Phase 2 dose-ranging study of MK-5442 in postmenopausal women with osteoporosis was terminated. Results for the trial were posted in October 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | Phase 2 | Status: TERMINATED | Results posted: 2012-10-10